Evaluation of Surgical Margin Status in Patients With Salivary Gland Cancer

Authors:

Abstract
Salivary gland cancers encompass a highly diverse range of pathologic entities, with more than 20 different histologic presentations listed by the World Health Organization.1 These cancers arise in various anatomic locations, including the major (named) salivary glands and the minor salivary glands in the mucosa of the upper aerodigestive tract. Surgical resection has established efficacy as the primary treatment for salivary gland cancer compared with radiotherapy.2 However, the intrinsic heterogeneity of the histologic types and the variety of anatomic locations has made it challenging to analyze the margins of surgical resection, resulting in a paucity of published literature addressing this issue.3 Salivary gland cancers are often in proximity to or involve crucial anatomic structures, the surgical interruption or sacrifice of which may impart substantial functional or aesthetic morbidity. Because close or positive margins are not uncommon, adjuvant radiotherapy may be indicated in such patients, but this treatment can result in the impairment of salivary function and lead to a negative influence on patients’ quality of life. Thus, we face a clinical dilemma in this group of patients: we must assess the histologic risk of the cancer and its biological behavior on local control and survival and balance this with the beneficial oncologic effects of adjuvant radiotherapy and its subsequent adverse effects.

This publication has 25 references indexed in Scilit: